Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a phase 1, open-label, randomized study. The objective of this study is to evaluate the PK, safety and tolerability of orally administered single-dose HRS-5041 in healthy Caucasian male participants.
Epistemonikos ID: de1dc6f15b638b8cd02992c0cb744bf7ec7622ff
First added on: Sep 01, 2024